{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:50:14Z","timestamp":1785757814238,"version":"3.56.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ajg.2026.07.009","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:34:27Z","timestamp":1785756867000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dynamic changes in non-invasive fibrosis scores as early predictors of deterioration in chronic hepatitis B"],"prefix":"10.1016","author":[{"given":"Muhammet Salih","family":"Tarhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajg.2026.07.009_bb0005","unstructured":"World Health Organization. Global hepatitis report 2024: action for access in low- and middle-income countries. https:\/\/www.who.int\/publications\/i\/item\/9789240091672; 2024, Accessed 25 November 2025."},{"issue":"2","key":"10.1016\/j.ajg.2026.07.009_bb0010","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection","volume":"67","author":"Lampertico","year":"2017","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.ajg.2026.07.009_bb0015","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1053\/j.gastro.2012.02.017","article-title":"Noninvasive methods to assess liver disease in patients with hepatitis B or C","volume":"142","author":"Castera","year":"2012","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.ajg.2026.07.009_bb0020","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2015.11.012","article-title":"Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients","volume":"64","author":"Ray Kim","year":"2016","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.ajg.2026.07.009_bb0025","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1136\/gutjnl-2015-309260","article-title":"The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa","volume":"65","author":"Lemoine","year":"2016","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.ajg.2026.07.009_bb0030","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade","volume":"33","author":"Johnson","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.ajg.2026.07.009_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2022.100557","article-title":"The ALBI score: from liver function in patients with HCC to a general measure of liver function","volume":"4","author":"Toyoda","year":"2022","journal-title":"JHEP Reports"},{"issue":"5","key":"10.1016\/j.ajg.2026.07.009_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051177","article-title":"On-treatment changes in FIB-4 and 1-year FIB-4 values help identify patients with chronic hepatitis B receiving entecavir therapy who have the lowest risk of hepatocellular carcinoma","volume":"12","author":"Wang","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ajg.2026.07.009_bb0045","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1038\/s41598-023-36668-2","article-title":"Improved on-treatment fibrosis-4 during antiviral therapy and lower hepatocellular carcinoma risk in cirrhotic patients with hepatitis B","volume":"13","author":"Oh","year":"2023","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.ajg.2026.07.009_bb0050","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/jgh.13667","article-title":"Long-term progression of viral load and serum markers of fibrosis among treated and untreated patients with chronic hepatitis B","volume":"32","author":"Li","year":"2017","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.ajg.2026.07.009_bb0055","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/hep.27069","article-title":"Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C","volume":"60","author":"Vergniol","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ajg.2026.07.009_bb0060","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jhep.2022.10.035","article-title":"Longitudinal changes in fibrosis markers are associated with risk of cirrhosis and hepatocellular carcinoma in non-alcoholic fatty liver disease","volume":"78","author":"Cholankeril","year":"2023","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.ajg.2026.07.009_bb0065","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.3390\/diagnostics12112646","article-title":"Dynamic changes in liver stiffness in patients with chronic hepatitis B undergoing antiviral therapy","volume":"12","author":"Lazar","year":"2022","journal-title":"Diagnostics"},{"issue":"51","key":"10.1016\/j.ajg.2026.07.009_bb0070","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013696","article-title":"FIB-4 index serves as a noninvasive prognostic biomarker in patients with hepatocellular carcinoma: a meta-analysis","volume":"97","author":"Zhang","year":"2018","journal-title":"Medicine"},{"issue":"7","key":"10.1016\/j.ajg.2026.07.009_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271790","article-title":"Hormone replacement therapy is associated with reduced hepatocellular carcinoma risk and improved survival in postmenopausal women with hepatitis B: a nationwide long-term population-based cohort study","volume":"17","author":"Wang","year":"2022","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ajg.2026.07.009_bb0080","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000085","article-title":"Influence of gender and reproductive factors on liver fibrosis in patients with chronic hepatitis b infection","volume":"10","author":"Xiong","year":"2019","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"1","key":"10.1016\/j.ajg.2026.07.009_bb0085","doi-asserted-by":"crossref","DOI":"10.1038\/srep37498","article-title":"Female gender lost protective effect against disease progression in elderly patients with chronic hepatitis B","volume":"6","author":"You","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.ajg.2026.07.009_bb0090","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.cld.2007.08.005","article-title":"Long-term outcomes in hepatitis B: the REVEAL-HBV study","volume":"11","author":"Chen","year":"2007","journal-title":"Clin Liver Dis"},{"issue":"10","key":"10.1016\/j.ajg.2026.07.009_bb0095","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154833","article-title":"Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B","volume":"132","author":"Choi","year":"2022","journal-title":"J. Clin. Invest."}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197926000882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197926000882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:34:30Z","timestamp":1785756870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197926000882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":19,"alternative-id":["S1687197926000882"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2026.07.009","relation":{},"ISSN":["1687-1979"],"issn-type":[{"value":"1687-1979","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dynamic changes in non-invasive fibrosis scores as early predictors of deterioration in chronic hepatitis B","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2026.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}